17 studies found for:    LAM | Open Studies | NIH, U.S. Fed
Show Display Options
RSS Create an RSS feed from your search for:
LAM | Open Studies | NIH, U.S. Fed
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Recruiting Study of the Disease Process of Lymphangioleiomyomatosis
Conditions: Lung Disease;   Pneumothorax;   Tuberous Sclerosis
Intervention:
2 Recruiting Nebulized or Inhaled Albuterol for Lymphangioleiomyomatosis
Condition: Lymphangioleiomyomatosis
Interventions: Drug: albuterol inhaler;   Procedure: PFT;   Drug: albuterol nebulizer
3 Recruiting Safety Study of Sirolimus and Hydroxychloroquine in Women With Lymphangioleiomyomatosis
Condition: Lymphangioleiomyomatosis
Intervention: Drug: sirolimus and hydroxychloroquine
4 Unknown  Trial of Aromatase Inhibition in Lymphangioleiomyomatosis
Condition: Lymphangioleiomyomatosis
Interventions: Drug: Letrozole;   Drug: Placebo
5 Recruiting Role of Helicobacter Pylori and Its Toxins in Lung and Digestive System Diseases
Conditions: Pulmonary Disease;   Oropharyngeal Disease;   Lymphangioleiomyomatosis;   Pulmonary Fibrosis;   Asthma;   Sarcoidosis
Intervention:
6 Recruiting Optimizing Clinical Outcomes in HIV-Infected Adults & Children
Conditions: Tuberculosis Diagnosis;   HIV
Intervention: Other: Xpert MTB/RIF Tuberculosis diagnostic tool
7 Recruiting VA MERIT: A Comparative Efficacy Study: Treatment of Non-Healing Diabetic Foot Ulcers
Condition: Diabetic Foot Ulcer
Interventions: Device: SECONDARY dressing gauze and tape;   Procedure: debridement, irrigation;   Device: Dermagraft™;   Device: Oasis™
8 Recruiting Clinical and Genetic Characterization of Individuals With Achromatopsia
Condition: Achromatopsia
Intervention:
9 Recruiting Clinical and Basic Investigations Into Known and Suspected Congenital Disorders of Glycosylation
Condition: Congenital Disorders of Glycosylation
Intervention:
10 Not yet recruiting Evaluation of an Integrated Microfinance and Depression Care Program for Women
Conditions: Depression;   Anxiety
Interventions: Behavioral: LIFE-DM;   Drug: Guideline Antidepressant Care
11 Recruiting Characterization of the Pathogenesis of Primary and Secondary Lymphatic Disorders
Conditions: Lymphangiomatosis;   Lymphedema;   Lymphangiectasia;   Pulmonary Lymphangiectasia
Intervention:
12 Recruiting Bevacizumab With or Without Monoclonal Antibody Therapy in Treating Patients With Metastatic Kidney Cancer
Conditions: Clear Cell Renal Cell Carcinoma;   Recurrent Renal Cell Cancer;   Stage IV Renal Cell Cancer;   Type 1 Papillary Renal Cell Carcinoma;   Type 2 Papillary Renal Cell Carcinoma
Interventions: Biological: bevacizumab;   Biological: anti-endoglin monoclonal antibody TRC105;   Other: laboratory biomarker analysis;   Other: pharmacological study
13 Recruiting S0931, Everolimus in Treating Patients With Kidney Cancer Who Have Undergone Surgery
Condition: Kidney Cancer
Interventions: Drug: everolimus;   Other: placebo
14 Recruiting International Study of Comparative Health Effectiveness With Medical and Invasive Approaches (ISCHEMIA)
Conditions: Cardiovascular Diseases;   Coronary Disease;   Coronary Artery Disease;   Heart Diseases;   Myocardial Ischemia
Interventions: Procedure: cardiac catheterization;   Procedure: coronary artery bypass graft surgery;   Procedure: percutaneous coronary intervention;   Behavioral: Lifestyle;   Drug: Medication
15 Recruiting Digital Colposcopy in Finding Cervical Intraepithelial Neoplasia
Conditions: Cervical Cancer;   Precancerous Condition
Interventions: Other: histological technique;   Other: laboratory biomarker analysis;   Procedure: colposcopic biopsy;   Procedure: colposcopy;   Procedure: light-scattering spectroscopy;   Procedure: loop electrosurgical excision procedure
16 Recruiting Trial of Oral Valproic Acid for Retinitis Pigmentosa
Condition: Retinitis Pigmentosa
Interventions: Drug: Valproic Acid;   Drug: Placebo
17 Recruiting Safety Study of an Adeno-associated Virus Vector for Gene Therapy of Leber's Hereditary Optic Neuropathy (LHON) Caused by the G11778A Mutation
Conditions: Leber's Hereditary Optic Neuropathy;   G11778A Gene Mutation;   Human Mitochondrial ND4 Gene
Interventions: Drug: scAAV2-P1ND4v2 5.00x10e9 vg (Low),;   Drug: scAAV2-P1ND4v2 2.46X10e10 vg (Med);   Drug: scAAV2-P1ND4v2 1.0X10e11vg (High)

Indicates status has not been verified in more than two years